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Defective glutamate and K+ clearance by cortical
astrocytes in familial hemiplegic migraine type 2
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Abstract
Migraine is a common disabling brain disorder. A subtype of
migraine with aura (familial hemiplegic migraine type 2: FHM2) is
caused by loss-of-function mutations in a2 Na
+,K+ ATPase (a2NKA),
an isoform almost exclusively expressed in astrocytes in adult
brain. Cortical spreading depression (CSD), the phenomenon that
underlies migraine aura and activates migraine headache mecha-
nisms, is facilitated in heterozygous FHM2-knockin mice with
reduced expression of a2NKA. The mechanisms underlying an
increased susceptibility to CSD in FHM2 are unknown. Here, we
show reduced rates of glutamate and K+ clearance by cortical
astrocytes during neuronal activity and reduced density of GLT-1a
glutamate transporters in cortical perisynaptic astrocytic
processes in heterozygous FHM2-knockin mice, demonstrating key
physiological roles of a2NKA and supporting tight coupling with
GLT-1a. Using ceftriaxone treatment of FHM2 mutants and partial
inhibition of glutamate transporters in wild-type mice, we obtain
evidence that defective glutamate clearance can account for most
of the facilitation of CSD initiation in FHM2-knockin mice, pointing
to excessive glutamatergic transmission as a key mechanism
underlying the vulnerability to CSD ignition in migraine.
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Introduction
Migraine is a common disabling brain disease, which manifests
itself as recurrent attacks of typically throbbing and unilateral
headache with certain associated features such as nausea and
hypersensitivity to sensory stimuli. In a third of patients, the head-
ache is preceded by transient focal symptoms that are most
frequently visual (migraine with aura: MA). Increasing evidence
supports a key role of cortical spreading depression (CSD) in
migraine pathogenesis in that CSD underlies migraine aura
(Lauritzen, 1994; Noseda & Burstein, 2013; Pietrobon & Moskowitz,
2013, 2014) and may trigger the headache mechanisms (Bolay et al,
2002; Ayata et al, 2006; Zhang et al, 2010, 2011; Karatas et al,
2013; Pietrobon & Moskowitz, 2014; Zhao & Levy, 2015). CSD is a
slowly propagating wave of rapid nearly complete depolarization of
brain cells lasting about 1 min that silences brain activity for several
min (Somjen, 2001; Pietrobon & Moskowitz, 2014). The mecha-
nisms of the primary brain dysfunction underlying the susceptibility
to CSD ignition in the human brain and the onset of a migraine
attack remain largely unknown and are a major open issue in the
neurobiology of migraine.
Migraine has a strong multifactorial genetic component (de Vries
et al, 2009; Russell & Ducros, 2011; Ferrari et al, 2015). As for many
other multifactorial diseases, rare monogenic forms that phenocopy
most or all the clinical features of the disorder are helpful for eluci-
dating the molecular and cellular mechanisms of the disease. Famil-
ial hemiplegic migraine (FHM) is a rare monogenic autosomal
dominant form of MA. Apart from motor features and longer dura-
tion of the aura, typical FHM attacks resemble MA attacks and both
types of attacks may alternate in patients and co-occur within
families (de Vries et al, 2009; Russell & Ducros, 2011; Ferrari et al,
2015).
FHM type 2 (FHM2) is caused by mutations in ATP1A2, the gene
encoding the a2 subunit of the Na
+,K+ ATPase (NKA) (De Fusco
et al, 2003; Bøttger et al, 2012). The a2 NKA is expressed primarily
in neurons during embryonic development and at the time of birth
and almost exclusively in astrocytes in the adult brain (McGrail
et al, 1991; Cholet et al, 2002; Ikeda et al, 2003; Moseley et al,
2003). The a2 NKA is thought to play an important role in K
+ clear-
ance during neuronal activity, but direct evidence is missing mainly
because selective inhibitors allowing to distinguish the contributions
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of the glial a2 and the neuronal a3 NKA are still lacking (Ransom
et al, 2000; D’Ambrosio et al, 2002; Larsen & MacAulay, 2014;
Larsen et al, 2014). An important role of a2 NKA in glutamate (Glu)
clearance is suggested by its colocalization with the Glu transporters
(GluTs) GLT-1 and GLAST in astrocytic processes surrounding
glutamatergic synapses in adult somatic sensory cortex (Cholet
et al, 2002) and by the association between GluTs and a2 NKA in
the same macromolecular complex (Rose et al, 2009). However, this
association is not specific for the a2 NKA (Rose et al, 2009; Genda
et al, 2011; Illarionava et al, 2014) and, although ouabain pharma-
cology indicates a preferential functional coupling of GluTs with a2
NKA in cultured astrocytes (Pellerin & Magistretti, 1997; but see
Rose et al, 2009; Illarionava et al, 2014), the role of the a2 pump in
clearance of synaptically released Glu during neuronal activity
remains unclear, given the lack of functional data in brain slices.
FHM2 mutations cause the complete or partial loss of function of
a2 NKA (De Fusco et al, 2003; Pietrobon, 2007; Tavraz et al, 2008,
2009; Leo et al, 2011; Bøttger et al, 2012; Schack et al, 2012; Swarts
et al, 2013; Weigand et al, 2014). a2 NKA protein is barely detect-
able in the brain of homozygous knockin (KI) mice carrying the
pathogenic W887R FHM2 mutation and is halved in the brain of
heterozygous W887R/+ mutants (Leo et al, 2011). These FHM2-KI
mice show a lower threshold for CSD induction and an increased
velocity of CSD propagation, in vivo (Leo et al, 2011), similar to KI
mouse models of FHM type 1 (FHM1) (van den Maagdenberg et al,
2004, 2010; Eikermann-Haerter et al, 2009) and to a mouse model
of a familial advanced sleep syndrome in which all patients also suf-
fered from MA (Brennan et al, 2013).
The mechanisms underlying an increased susceptibility to CSD in
FHM2 are unknown, although impaired Glu and/or K+ clearance by
astrocytes have been suggested as hypothetical mechanisms
(Moskowitz et al, 2004; Pietrobon, 2007).
Here, to test these hypotheses and to gain insights into the physio-
logical role of the a2 NKA, we investigated the functional conse-
quences of the W887R FHM2-causing mutation on Glu and K+
clearance by cortical astrocytes during neuronal activity in acute
cortical slices. Our findings indicate that the rates of Glu and K+
clearance by cortical astrocytes are reduced in heterozygous W887R/+
KI mice and that the density of GLT-1a in the membrane of astro-
cytic processes surrounding cortical glutamatergic synapses is
reduced by 50% in the FHM2 mutants. Using an in vitro model of
CSD and ceftriaxone treatment in FHM2-KI mice as well as pharma-
cological inhibition of a fraction of GluTs in wild-type (WT) mice,
we provide evidence that the defective Glu clearance can account
for most of the facilitation of CSD initiation in the FHM2 mouse
model.
Results
To investigate whether the reduced membrane expression of the a2
NKA in heterozygous W887R/+ FHM2-KI mice causes a reduced rate
of Glu clearance by cortical astrocytes during neuronal activity, we
took advantage of the fact that i) Glu uptake into astrocytes by
GluTs is electrogenic, and therefore can be monitored electrophysio-
logically, and ii) the time course of the Glu transporter current
elicited in astrocytes upon extracellular neuronal stimulation in
hippocampal slices (the so-called synaptically activated transporter
current, STC) reflects, to some extent, the time course of Glu clear-
ance by astrocytes and provides a relative indication of how rapidly
synaptically released Glu is taken up from extracellular space
(Bergles & Jahr, 1997; Diamond, 2005). The time course of the STC
is also affected by the electrotonic properties of the astrocytic
membrane, while axon propagation, release asynchrony, glutamate
diffusion, and the kinetics of the transporters contribute insignifi-
cantly in hippocampal slices (Bergles & Jahr, 1997; Diamond, 2005);
thus, the decay kinetics of the STC reflects the rate of Glu clearance
filtered by the electrotonic properties of astrocytes (Diamond, 2005).
Interestingly, the time course of the STC provides a measure of the
rate of Glu clearance that is independent of the amount of Glu
released (Diamond & Jahr, 2000; Diamond, 2005; Unichenko et al,
2012).
We measured the STC in cortical astrocytes by recording the
inward current evoked in layer 1 astrocytes (held at 90 mV, close
to the resting potential) by the stimulation of neuronal afferents
with an extracellular electrode located in layer 1, 200 lm from the
patch-clamped astrocyte, in acute slices of the somatic sensory
cortex from P22-23 WT and FHM2-KI mice, in the presence of antag-
onists of Glu and GABA receptors (Fig 1A) (Bergles & Jahr, 1997;
Bernardinelli & Chatton, 2008). The inward current evoked in astro-
cytes by a single pulse stimulation comprised a rapidly rising and
decaying component (complete decay in few tens of ms) and a
sustained component (Fig 1B, trace a). The rapidly decaying compo-
nent was completely inhibited by the GluTs inhibitor TFB-TBOA
(TBOA), identifying it as the STC (Fig 1B). The STC can thus be
obtained by subtracting the residual current remaining in the pres-
ence of TBOA from the total inward current (trace a-b in Fig 1B)
(Scimemi & Diamond, 2013). The STC can also be obtained by
subtracting from the total inward current an exponential waveform
(trace c in Fig 1C) that approximates the average TBOA-insensitive
current (Fig 1C, top trace) obtained as described in Materials and
Methods (Devaraju et al, 2013; Scimemi & Diamond, 2013). As in
hippocampal slices (Diamond & Jahr, 2000; Diamond, 2005), also in
barrel cortex slices the decay kinetics of the STC slowed down when
the density of GluTs was reduced by subsaturating concentrations
of DL-TBOA (Appendix Fig S1A), as expected for a reduced rate of
Glu clearance and a longer lifetime of synaptically released Glu in
the extracellular space. Moreover, changing the intensity of extracel-
lular stimulation (and hence the number of stimulated fibers and
the amount of Glu released) changed the STC amplitude without
affecting the STC decay kinetics (Appendix Fig S1B). Thus, to obtain
a measure of the rate of clearance of synaptically released Glu by
cortical astrocytes, which is not affected by the amount of Glu
released by extracellular stimulation, we fitted with an exponential
function the decay of the STC (Fig 1).
The STC isolated pharmacologically in cortical astrocytes of WT
mice decayed with an exponential time course with time constant
s = 6.80  0.19 ms (Fig 1B). The STC isolated in a larger number
of cells using the exponentially rising function that approximates
the average TBOA-insensitive current (Fig 1C) decayed with a simi-
lar time course (6.46  0.13 ms; unpaired t-test, P = 0.15). The
decay kinetics of the STC elicited in cortical astrocytes of heterozy-
gous W887R/+ FHM2-KI mice were slower compared to those in
WT astrocytes, as shown by the significantly larger time constant of
decay of both the STC isolated pharmacologically (s = 7.97 
0.31 ms) and the STC isolated nonpharmacologically in a larger
EMBO Molecular Medicine Vol 8 | No 8 | 2016 ª 2016 The Authors
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Figure 1. The rate of glutamate clearance by cortical astrocytes, as deduced from the decay kinetics of the synaptically activated glutamate transporter
current (STC) elicited by single pulse stimulation, is slower in W887R/+ FHM2-knockin (KI) relative to wild-type (WT) mice.
A Scheme of the STC recording paradigm. The currents elicited by extracellular stimulation in layer 1 were measured in a voltage-clamped layer 1 astrocyte located at
200 lm from the stimulating electrode in an acute slice of mouse barrel cortex.
B Time constants of decay, sdecay, of the STC isolated pharmacologically in WT and FHM2-KI mice. Top, superimposed representative traces of the inward current
evoked in an astrocyte (held at 90 mV) by a single pulse stimulation (indicated by the arrow) in a WT slice, before (trace a) and after (trace b) application of a
saturating concentration of the GluT inhibitor TFB-TBOA (TBOA). The STC was obtained by subtracting the residual current remaining in the presence of TBOA from
the total inward current (trace a–b); the decay of the STC was best fitted by a single exponential function with s decay = 6.53 ms (in red). The bar plot shows the
average values of sdecay of the STC isolated pharmacologically in cortical slices (n = 13) from P22-23 WT (N = 7) and KI mice (n = 9; N = 3). STC sdecay is 17% higher
in KI compared to WT astrocytes (unpaired t-test: **P = 0.003). Hereafter, n indicates the number of slices and N indicates the number of mice. Data are
mean  SEM.
C sdecay of the STC isolated using an exponential waveform approximating the average TBOA-insensitive current in WT and KI mice. Top trace, average normalized
TBOA-insensitive current obtained by pooling the normalized TBOA-insensitive currents recorded in 16 WT and KI cells. This current was best fitted by an
exponentially rising function [1-exp (t/srise)] with srise = 2.35 ms (in green). The STC was obtained by subtracting from the total current elicited in the astrocyte
[a: same representative trace as in (B)] the exponential function A[1-exp (t/srise)] with srise = 2.35 ms and A equal to the maximal current measured in the astrocyte
at about 60 ms after stimulation (trace c); the decay of the STC (trace a–c) was best fitted by a single exponential function with sdecay = 6.49 ms (in red). The bar
plot shows the average values of sdecay of the STC isolated as shown in the top panel in cortical slices from P22-23 WT (n = 28; N = 11) and KI mice (n = 27; N = 9).
STC sdecay is 21% higher in KI compared to WT astrocytes (unpaired t-test: ***P < 0.0001). Data are mean  SEM.
Source data are available online for this figure.
ª 2016 The Authors EMBO Molecular Medicine Vol 8 | No 8 | 2016
Clizia Capuani et al Defective glutamate and K clearance in FHM2 cortex EMBO Molecular Medicine
969
Published online: June 27, 2016 
number of cells (s = 7.82  0.16 ms) (Fig 1). The slower decay of
the STC in FHM2-KI cortical slices indicates that the rate of clear-
ance of synaptically released Glu by cortical astrocytes is slower in
FHM2-KI compared to WT mice. The alternative interpretation that
the slower decay of the STC in FHM2-KI mice reflects a larger elec-
trotonic filtering in KI compared to WT astrocytes appears quite
unlikely, given the similar passive membrane properties measured
in KI and WT cortical astrocytes (see Materials and Methods) and
the unlikelihood that the astrocyte electrotonic properties are
affected by a 50% reduction in a2 NKA expression. Moreover, in the
unlikely case that, in contrast with the findings in hippocampal
slices (Diamond, 2005), other factors, such as release asynchrony or
axonal propagation, contribute significantly to the time course of
the STC in cortical slices, the alternative interpretation that a larger
contribution of these factors in FHM2-KI mice accounts for the
slower decay of the STC in KI slices seems also quite unlikely, given
that the FHM2 mutation affects a specific astrocytic NKA that is not
expressed in cortical axons (Cholet et al, 2002).
We next investigated whether the slowing down of Glu clearance
in FHM2-KI mice was larger after repetitive stimulation with trains
of 10 pulses at 50 or 100 Hz, as, for example, might be expected if
the binding capacity of the GluTs in layer 1 astrocytes is over-
whelmed during the train. In this case, the decay kinetics of the STC
elicited by the 10th pulse in the train should be slower than those of
the STC elicited by a single pulse stimulation (Diamond & Jahr,
2000). Indeed, in experiments in which single stimuli were alter-
nated with trains of 9 and 10 pulses at 50 or 100 Hz, the time
constants of decay of the STCs elicited by the 10th pulse of the high-
frequency trains (isolated as described in Materials and Methods:
Fig 2A) were significantly larger than those of the corresponding
STC elicited by a single pulse. For example, the time constant of the
STC elicited in WT astrocytes by the 10th pulse of a 50-Hz train,
s10 (50 Hz), was 7.56  0.16 ms (n = 23), while that elicited by a single
pulse in the same cells was s1 = 6.45  0.15 ms (n = 23; paired
t-test, P < 0.0001) and the average ratio s10/s1 (50 Hz) was 1.18 
0.02 (n = 23). The slowing of the STC after the train was larger in
FHM2-KI compared to WT mice (in KI: s10/s1 (50 Hz) =
1.26  0.03, n = 21; unpaired t-test, P = 0.021). The relative slow-
ing and the difference between WT and KI mice were more
pronounced after a 100-Hz train (s10/s1 (100 Hz) = 1.25  0.03,
n = 18, in WT versus s10/s1 (100 Hz) = 1.40  0.05, n = 14, in KI,
P = 0.009). As a consequence, the slowing down of Glu clearance in
FHM2-KI compared to WT mice was quantitatively larger after
repetitive stimulation than after single pulse stimulation and
increased with increasing stimulation frequency (Fig 2B). The time
constants of decay of the STCs elicited by the 10th pulse of 50-
and 100-Hz trains in FHM2-KI mice (s10(50 Hz) = 9.82  0.24;
s10(100 Hz) = 11.08  0.41 ms) were 30 and 37% larger than
those in WT mice, respectively (s10(50 Hz) = 7.56  0.16 ms;
s10(100 Hz) = 8.09  0.23 ms) (Fig 2B). For comparison, the time
constant of decay of the STC elicited by a single pulse was 21%
larger in FHM2-KI compared to WT mice (Fig 1).
Given the evidence of association in the same protein complex of
the glial GluTs (GLT-1 and GLAST) and the a2 NKA pump (Rose
et al, 2009; Illarionava et al, 2014) and of colocalization of the glial
GluTs with a2 NKA in astrocytic processes surrounding neocortical
glutamatergic synapses (Cholet et al, 2002), we investigated
whether the reduced expression of a2 NKA leads to a reduced
density of GLT-1 in the membrane of astrocytic processes surround-
ing cortical excitatory synapses (perisynaptic astrocytic processes:
PAPs). GLT-1 is the quantitatively dominant GluT in the brain and
mediates the majority of Glu clearance in the adult murine neocor-
tex (Haugeto et al, 1996; Rothstein et al, 1996; Tanaka et al, 1997;
Danbolt, 2001; Campbell et al, 2014).
We obtained a first indication that GLT-1 expression in the vicin-
ity of cortical glutamatergic synapses was decreased in FHM2-KI
mice from double-labeling immunofluorescence of GLT-1a and the
vesicular glutamate transporter VGLUT1 in neocortical sections.
GLT-1a is the predominant brain GLT-1 isoform (Chen et al, 2004;
Berger et al, 2005; Holmseth et al, 2009), and VGLUT1 is expressed
in the large majority of cortical excitatory terminals (Kaneko et al,
2002). Quantitative analysis of GLT-1a immunoreactivity (ir)
showed that the mean size of the GLT-1a-positive (GLT-1a+) ir
puncta (green) that overlapped with VGLUT1+ ir puncta (red) was
reduced by 18% in FHM2-KI mice (0.47  0.03 lm2) compared to
WT (0.57  0.03 lm2) (Fig 3). The percentages of GLT-1a+ puncta
overlapping with VGLUT1+ puncta were comparable (49  3% in
KI; 46  4% in WT). As a change in size of ir puncta has been
considered strongly suggestive of a change in protein expression
(Bozdagi et al, 2000; Bragina et al, 2006; Omrani et al, 2009), the
reduced size of the GLT-1a+ puncta overlapping with VGLUT1+
puncta is consistent with a reduced GLT-1a expression in the vicin-
ity of cortical glutamatergic synapses in W887R/+ KI mice.
The majority of overlapping GLT-1a/VGLUT1 puncta colocalized
with a2 NKA (81  2%), as revealed by triple-labeling immunofluo-
rescence of GLT-1a, VGLUT1, and a2 NKA in WT cortical sections
(Fig EV1). This suggests a strict colocalization of GLT-1a and a2
NKA in the astrocytic processes close to glutamatergic synapses,
given that in the adult brain a2 NKA is expressed almost exclusively
in astrocytes and is not present in cortical axon terminals (McGrail
et al, 1991; Cholet et al, 2002).
We then used post-embedding immunogold electron microscopy
(EM) in cerebral cortex sections to study the density of GLT-1a gold
particles associated with the membrane of PAPs. In line with previ-
ous studies (e.g. Melone et al, 2009; Omrani et al, 2009), GLT-1a
particles were at the membrane and in the cytoplasm of both PAPs
(Fig 4A) and axon terminals (AxT) forming asymmetric synaptic
contacts (Fig 4B); the density of gold particles was significantly
higher on the plasma membrane (i.e. within 15 nm of the extracel-
lular side of the membrane) than in the cytoplasm (Table 1). The
total and plasma membrane densities of GLT-1a gold particles in
PAPs were reduced by 41 and 48%, respectively, in FHM2-KI
compared to WT mice (Fig 4A, Table 1). The reduction in GLT-1a
density in the membrane of PAPs is quantitatively similar to the
reduction in a2 NKA protein level in cortical crude synaptic
membranes from W887R/+ KI mice revealed by Western blotting
(about 50%: Leo et al, 2011). Interestingly, in contrast with the
decreased density of GLT-1a in PAPs, both the total and the plasma
membrane densities of GLT-1a were unaltered in FHM2-KI AxTs
(Fig 4B, Table 1). The similar density of GLT-1a in FHM2 and WT
AxTs correlates with, and likely reflects, the absence of a2 NKA in
cortical AxTs (Cholet et al, 2002).
The EM data, together with the strict colocalization of a2 NKA
and GLT-1a in the vicinity of glutamatergic synapses (Fig EV1),
suggest a necessary tight coupling between a2 NKA and GLT-1a in
PAPs and point to the reduced expression of GluTs in PAPs as the
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main mechanism underlying the reduced rate of Glu clearance by
astrocytes in FHM2-KI mice.
To investigate whether the reduced expression of the a2 NKA in
W887R/+ KI mice causes a reduced rate of K+ clearance by
astrocytes during neuronal activity, we took advantage of the fact
that (i) as a consequence of the very high expression of K+ chan-
nels that are open at negative resting voltages, the astrocyte passive
conductance is essentially K+ selective and the astrocyte membrane
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Figure 2. The slowing down of glutamate clearance in FHM2-KI relative to WT mice is larger after a train of action potentials at high frequency than after a
single action potential.
A Isolation of the STC elicited by the last pulse of a high-frequency train of action potentials. Left: superimposed representative traces of the inward current evoked in
an astrocyte (held at 90 mV) by extracellular stimulation with a train of 10 pulses (trace a: black) and a train of nine pulses (trace b: brown) at 50 Hz in a WT
cortical slice. The inward current elicited by the 10th pulse was obtained by subtracting the current elicited by nine pulses from that elicited by 10 pulses (trace a-b).
Right: The STC elicited by the 10th pulse (trace a-b-c) was obtained by subtracting the exponential function that simulates the TBOA-insensitive current elicited by a
single pulse (trace c, obtained as in Fig 1C) to the 10-9 pulses difference current (trace a-b). The decay of the STC elicited by the 10th pulse was best fitted by a single
exponential function with sdecay = 8.04 ms (in red).
B sdecay of the STC elicited by the 10
th pulse of 50-Hz (s10 (50 Hz), left panel) and 100-Hz (s10 (100 Hz), right panel) trains in layer 1 astrocytes in acute cortical slices from
P22-23 WT (n = 23; N = 10 for 50 Hz; n = 18; N = 8 for 100 Hz) and KI (n = 21; N = 9 for 50 Hz and n = 14; N = 7 for 100 Hz) mice. The STC elicited by the 10th
pulse was obtained as described in (A). STC s10 (50 Hz) and s10 (100 Hz) are 30% and 37% higher in KI compared to WT mice, respectively (unpaired t-test: ***P < 0.0001
in both cases). Data are mean  SEM.
Source data are available online for this figure.
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potential behaves as a good K+ electrode, rendering astrocytes
useful [K+]e biosensors (Meeks & Mennerick, 2007; Zhou et al,
2009; Hwang et al, 2014); (ii) the slowly decaying inward current
elicited in astrocytes upon extracellular neuronal stimulation in
acute brain slices is largely a K+ current that reflects [K+]e accumu-
lation due to neuronal K+ efflux and the accompanying change in
driving force through glial K+ channels (mainly inward rectifier
Kir channels judging from the sensitivity of the slow current to
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Figure 3. The size of GLT-1a-immunoreactive (ir) puncta overlapping with VGLUT1 ir puncta is reduced in the cortex of W887R/+ FHM2-KI mice, suggesting a
reduced expression of the glutamate transporter GLT-1a in the vicinity of cortical glutamatergic synapses.
A Simultaneous visualization of GLT-1a+ (green) and VGLUT1+ puncta (red) in first somatic sensory cortex (SI) of a WT and a KI mouse (P35). Arrows point to some GLT-
1a+ puncta overlaying with VGLUT1+ puncta (i.e. GLT-1a/VGLUT1-related puncta); framed regions (enlarged below) are examples of GLT-1a/VGLUT1-related puncta
(arrowheads). All microscopic fields are from layers II/III. Scale bar: 3.5 lm for left and right upper panels and 1 lm for enlarged framed areas.
B Percentage and size of GLT-1a+ puncta overlaying with VGLUT1 in P35 WT and KI mice. Left, percentage of GLT-1a+ puncta overlaying with VGLUT1 is comparable in
WT and KI mice (data were obtained from 14 and 18 fields of 20 × 20 lm from 2 WT and 2 KI mice (four sections/animal), respectively) (unpaired t-test: P = 0.52).
Right, size of GLT-1a/VGLUT1-related puncta is 18% reduced in KI mice (169 GLT-1a+ puncta analyzed from 2 mice) compared to WT (174 GLT-1a+ puncta analyzed
from 2 mice) (Mann–Whitney U-test: *P = 0.016). Data are mean  SEM.
Source data are available online for this figure.
EMBO Molecular Medicine Vol 8 | No 8 | 2016 ª 2016 The Authors
EMBO Molecular Medicine Defective glutamate and K clearance in FHM2 cortex Clizia Capuani et al
972
Published online: June 27, 2016 
low Ba2+ concentrations and to Kir4.1 knockout) (De Saint &
Westbrook, 2005; Djukic et al, 2007; Meeks & Mennerick, 2007;
Bernardinelli & Chatton, 2008; Shih et al, 2013; Sibille et al, 2014).
The time constant of decay of this slow current (hereafter called IK)
provides a measure of the rate of K+ clearance, which has been
shown to be equivalent to that obtained with [K+]e-sensitive micro-
electrodes (Meeks & Mennerick, 2007).
Therefore, to investigate the effect of the FHM2 mutation on K+
clearance, we recorded the current evoked in layer 1 astrocytes by
extracellular stimulation in layer 1, a protocol similar to that used
for the STC. However, the recordings were performed in the absence
of synaptic receptor blockers because postsynaptic Glu receptors, in
particular the NMDA receptors (NMDARs), represent a major source
of K+ efflux during neuronal activity (Poolos et al, 1987; De Saint &
Westbrook, 2005; Shih et al, 2013; Sibille et al, 2014). The IK
current elicited by repetitive stimulation (10 pulses at 50 Hz) in WT
astrocytes decayed with a time constant of 2.36  0.10 s, more than
two orders of magnitude more slowly than the STC (Fig 5). The
decay kinetics of IK elicited by the same stimulation in FHM2-KI
cortical slices were slower, as shown by the 22% larger time
constant (2.87  0.10 s) (Fig 5). This indicates that the reduced
membrane expression of the a2 NKA in W887R/+ FHM2-KI mice
causes a reduced rate of K+ clearance by cortical astrocytes follow-
ing neuronal activity. The measurement of the time constant of
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Figure 4. The density of GLT-1a in the membrane of cortical perisynaptic astrocytic processes is reduced in W887R/+ FHM2-KI mice, while the density of
GLT-1a in axon terminals is unaltered.
A Distribution of GLT-1a gold particles in astrocytic processes contacting asymmetric synapses (perisynaptic astrocytic processes: PAP) in SI of 5 WT and 5 KI
(two male, three female) mice (P34–35). In cortical PAP of KI mice, the density (particles/lm2) of total and membrane-associated gold particles (arrowheads) are
reduced compared to WT mice, whereas the density of cytoplasmic gold particles (arrows) is comparable to that in WT (see Table 1 for numerical values and
statistics).
B Distribution of GLT-1a gold particles in excitatory axon terminals forming asymmetric synaptic contact (AxT) in SI of P34-35 WT and KI mice. In cortical AxT of KI and
WT mice, GLT-1a density is comparable (arrowheads: membrane-associated gold particles; arrows: cytoplasmic gold particles) (see Table 1 for statistics).
Data information: All microscopic fields in (A) and (B) are from layers II/III. t, total density; cyt, cytoplasmic density; mem, membrane density. Scale bar: 100 nm. Data are
mean  SEM.
Source data are available online for this figure.
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decay of IK following stimulation with 10 pulses at 50 Hz in the
presence of Glu receptor blockers in WT (Ik sdecay = 2.38  0.09 s,
n = 18) and FHM2-KI astrocytes (Ik sdecay = 2.95  0.08 s, n = 16)
confirms this conclusion. In both genotypes, the time constants of
decay of IK are similar in the absence and presence of Glu receptors
blockers, and the slowing of K+ clearance in FHM2-KI cortical slices
is also similar in the two conditions.
We next investigated whether the slower rate of Glu clearance
during neuronal activity contributes to the facilitation of CSD in
W887R/+ FHM2-KI mice (Leo et al, 2011). First, we verified that in
the conditions in which we recorded the STC (P22 – 23 mice,
T = 30°C), CSD induced in acute cortical slices by brief pulses of
high K+ (as in Tottene et al, 2009) was facilitated in FHM2-KI mice,
as shown in vivo in adult mice (Leo et al, 2011). Brief pressure-
ejection KCl pulses of increasing duration were applied (at 5-min
intervals) onto the slice surface (layer 2/3) until a CSD was elicited,
as revealed by the associated changes in intrinsic optic signal (IOS).
The duration of the first pulse eliciting a CSD was taken as CSD
threshold and the rate of horizontal spread of the change in IOS as
CSD velocity (Fig 6A). The threshold for CSD induction was 28%
lower in FHM2-KI mice relative to WT (170  4 versus
236  8 ms) and the velocity of CSD propagation was 21% higher
(3.94  0.04, versus 3.26  0.05 mm/min) (Fig 6B). Thus, experi-
mental CSD in acute cortical slices from FHM2-KI mice was facili-
tated in the conditions in which a slowing of the rate of Glu
clearance compared to WT was shown. The smaller extent of facili-
tation compared to in vivo situation (where the CSD threshold was
decreased about 50% and the velocity increased about 40%) is at
least in part due to the younger age of the animals and the lower
temperature. In fact, the facilitation of CSD was larger in cortical
slices from older (P34 - 35) mice: the threshold for CSD induction
(T = 30°C) was 39% lower and the velocity of CSD propagation
26% higher in FHM2-KI relative to WT mice (Appendix Fig S2A). In
contrast with the very small number of spontaneous CSDs in both
WT and KI slices from P22 – 23 mice (2 out of 26 and 1 out of 28,
respectively), it was necessary to increase the perfusion rate of
P34 – 35 cortical slices (to 13 ml/min) to prevent the frequent igni-
tion of spontaneous CSDs in KI slices; in the latter, the frequency of
spontaneous CSDs (5 out of 31) remained larger than in WT (1 out
of 21) even at this high flow rate. On the other hand, the facilitation
of CSD was smaller in cortical slices from P34 – 35 mice at lower
temperature: the threshold for CSD induction (room T) was 22%
lower and the velocity of CSD propagation 20% higher in FHM2-KI
relative to WT mice (Appendix Fig S2B); no spontaneous CSDs were
observed.
As a first approach to study whether there is a causative relation-
ship between reduced rate of Glu clearance by astrocytes and CSD
facilitation, we investigated whether the facilitation of CSD in the
FHM2-KI mice could be (at least partially) rescued by systemic treat-
ment with ceftriaxone (Cef), a drug that increases the membrane
Table 1. Density of GLT-1a gold particles in perisynaptic astrocytic processes and axon terminals of asymmetric synapses of WT and W887R/+
FHM2-KI mice.
Density values are mean  SEM; n = the number of profiles. Comparison of densities between WT (N = 5) and KI (N = 5) and comparison of densities of
perisynaptic astrocytic processes, axon terminals, and background was made using Mann–Whitney U-test.
Localization WT (particles/lm2) FHM2 KI (particles/lm2) WT versus FHM2 KI
Nucleus (background) 0.59  0.02 (n = 30) 0.68  0.03 (n = 30)
Astrocytic processes° 26.14  1.80 (n = 481) 15.39  1.04 (n = 524) P < 0.0001
Plasma membrane 48.79  2.66 25.40  1.38 P < 0.0001
Cytoplasm 13.40  1.76 11.26  1.06 P = 0.058
Axon terminals° 7.05  0.65 (n = 148) 6.00  0.43 (n = 121) P = 0.44
Plasma membrane 20.15  1.77 17.34  1.57 P = 0.47
Cytoplasm 4.94  0.60 4.14  0.46 P = 0.45
°density of gold particles was significantly higher than background in PAPs and AxTs (P < 0.0001 for both WT and KI). The mean areas of PAP and AxT of all
sampled profiles used for immunogold analysis were comparable in WT and KI (PAP: 0.33  0.09 versus 0.38  0.05 lm2; Mann–Whitney U-test, P = 0.53; AxT:
0.71  0.17 versus 0.56  0.10 lm2; Mann–Whitney U-test, P = 0.55).
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Figure 5. The rate of K+ clearance by cortical astrocytes after a train of
action potentials is reduced in W887R/+ FHM2-KI compared to WT mice.
Left, superimposed representative traces of the normalized inward current
evoked in a WT (black trace) and a KI cortical astrocyte (blue trace) by
extracellular stimulation with a train of 10 pulses at 50 Hz in cortical slices. The
inset shows in an expanded time scale the portion of the traces indicated by the
dotted line. The slowly decaying current (sdecay = 2.00 s and 3.04 s for the WT
and KI trace, respectively) is largely a [K+]e-dependent K
+ current (IK) whose decay
kinetics provide a measure of the rate of K+ clearance by astrocytes (see text).
Right, time constant of decay of IK elicited by trains of 10 pulses at 50 Hz in
cortical astrocytes from P22-23WT (n = 21; N = 12) and KI mice (n = 20; N = 8).
IK sdecay is 22% higher in KI compared to WT astrocytes (unpaired t-test:
**P = 0.001). Data are mean  SEM.
Source data are available online for this figure.
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expression of GLT-1 in neocortex (Bellesi et al, 2009). Indeed,
Western blotting of cortical crude synaptic membranes and double-
labeling immunofluorescence of GLT-1a and VGLUT1 in cortical
sections from WT mice that had been injected for 8 days with either
Cef (200 mg/kg) or saline showed a 63% increase in GLT-1a protein
(Fig 7A) and a 58% increase in the mean size of the GLT-1a+ puncta
overlapping with VGLUT1 in Cef-treated compared to saline-treated
control animals (0.84  0.03 lm2 versus 0.53  0.03 lm2; Fig 7B).
Threshold of CSD induction and velocity of CSD propagation were
measured in slices from P30-33 FHM2-KI mice that had been
injected for 7–8 days with either Cef or saline. At this age, the
frequency of spontaneous CSDs was relatively small (in 7 out of 47
slices from saline-injected KI mice) even using 6 ml/min perfusion
rate. Moreover, at this age, a2 NKA and GLT-1 are expressed at very
close to adult levels (Orlowski and Lingrel, 1988; Furuta et al, 1997;
Ullensvang et al, 1997). The threshold for CSD induction was
slightly (12%), but significantly, increased in cortical slices from
Cef-treated compared to saline-treated FHM2-KI mice (162  5
versus 145  5 ms) (Fig 7C), and the frequency of spontaneous
CSDs (2 out of 40 slices) was decreased in Cef-treated mice. The
velocity of CSD propagation was similar in cortical slices from Cef-
and saline-treated FHM2-KI mice (3.82  0.08 versus 3.83  0.07)
(Fig 7C). These findings indicate that Cef treatment rescues a small
fraction of the facilitation of CSD induction in FHM2-KI mice with-
out affecting the facilitation of CSD propagation.
Given the findings suggesting a necessary tight coupling
between a2 NKA and GLT-1a in PAPs, we asked whether Cef
effectively increased the density of GLT-1a in cortical PAPs of
W8887R/+ KI mice having 50% reduced a2 NKA expression. We
used post-embedding EM to measure the density of GLT-1a gold
particles associated with the membrane of PAPs in cortical sections
from Cef- and saline-injected FHM2-KI mice. Interestingly, while
the density of the membrane pool of GLT-1a in AxTs was larger in
Cef-treated than in saline-treated FHM2-KI mice, the density of
GLT-1a gold particles in the membrane of PAPs was similar in
Cef- and saline-treated KI mice (Fig 8A and B, and Table 2).
Accordingly, the GLT-1a protein expression level and the size of
the GLT-1a+ ir puncta that overlapped with VGLUT1 ir in the
cortex of Cef- and saline-treated FHM2-KI mice were similar
(Fig 8C and D). This is consistent with the Cef-induced increase
in GLT-1a only at AxTs, given the relatively small fraction of
GLT-1a in AxTs relative to that in PAPs (and the limit of resolu-
tion of confocal microscopy) (Chen et al, 2004; Melone et al,
2009). These findings provide an explanation for the relative inef-
ficacy of Cef in the rescue of CSD facilitation and provide further
support to the idea of a necessary tight coupling between a2 NKA
and GLT-1a in PAPs. Given that Cef did not increase the density
of GLT-1a in PAPs, the partial rescue of the facilitation of CSD
induction in Cef-treated FHM2-KI mice may be due to the
increased Glu reuptake in AxTs (due to higher GLT-1a expression)
and/or to some other effect of Cef not related to GLT-1 expres-
sion. Mechanisms involving changes in expression of the a2 NKA
or the glial Glu-cystine antiporter xCT (that appears to be coregu-
lated with GLT-1 in nucleus accumbens after chronic treatment
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Figure 6. Facilitation of CSD induction and propagation in acute cortical slices of W887R/+ FHM2-KI mice.
A Images of a cortical slice before (t = 0) and after (t = 15.6 s) pressure ejection of a high KCl pulse that elicits a CSD (top panels), showing that the propagating CSD is
associated with a change in light transmittance. Scale bar: 500 lm. The traces below show representative changes in intrinsic optical signal (IOS) relative to
background measured in a WT and a KI cortical slice during CSD propagation at increasing times and distances from the KCl puff, as indicated in color code in the
right image on the top. The velocity of CSD propagation, obtained from the rate of horizontal spread of the change in IOS, in these two representative WT and KI
slices is 3.11 and 4.14 mm/min, respectively.
B Stimulation threshold for CSD induction (CSD threshold) and rate of CSD propagation (CSD velocity) in WT (n = 24; N = 3) and KI (n = 27; N = 8) cortical slices from
P22-23 mice. CSD threshold is expressed as duration of the first KCl pulse eliciting a CSD. CSD threshold is 28% lower (Mann–Whitney U-test, ***P < 0.0001) and CSD
velocity 21% higher (unpaired t-test: ***P < 0.0001) in KI compared to WT mice. Data are mean  SEM.
Source data are available online for this figure.
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with cocaine or alcohol: (Knackstedt et al, 2010; Rao & Sari,
2014)) or Kir4.1 [the glial K+ channel that plays a key role in K+
spatial buffering: (Djukic et al, 2007; Kofuji & Newman, 2004)] do
not seem to play a role, since the protein level of a2 NKA, xCT,
and Kir4.1 was not affected by Cef treatment of FHM2-KI mice
(Fig EV2).
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Figure 7. The CSD threshold is increased in cortical slices of FHM2-KI mice after Cef treatment that increases the GLT-1a expression in WT mice.
A Western blottings of GLT-1a in cortical crude synaptic membranes of P39 WT mice following Cef treatment for 8 days. GLT-1a levels are significantly increased in
mice treated with Cef (Cef WT, N = 4) compared to control saline-injected mice (Ctr WT, N = 4) (Mann–Whitney U-test: *P = 0.028). Data are mean  SEM.
B Visualization of GLT-1a+ puncta (green) and VGLUT1+ puncta (red) in sections from SI of P45-46 WT mice that were treated with saline (Ctr WT) or Cef (Cef WT).
Arrows point to some GLT-1a/VGLUT1-related puncta. Framed regions (enlarged below) are examples of GLT-1a/VGLUT1-related puncta (arrowheads). Right, Cef
treatment increased significantly the size of GLT-1a+ puncta overlaying VGLUT1 (142 and 186 GLT-1a+ puncta analyzed from 4 Ctr WT and 4 Cef WT mice,
respectively; 3 sections/animal) (Mann–Whitney U-test: ***P < 0.0001). Data are mean  SEM. All microscopic fields are from layers II/III. Scale bar: 3.5 lm for left
and right upper panels and 1 lm for enlarged framed areas.
C CSD threshold and CSD velocity in cortical slices from P30-33 KI mice that were injected with saline (Ctr KI, n = 38; N = 7) or Cef (Cef KI, n = 31; N = 6). CSD threshold
is 12% higher (Mann–Whitney U-test: *P = 0.02) in Cef-treated compared to saline-treated KI mice. CSD velocity is not altered by Cef treatment (P = 0.90). Data are
mean  SEM.
Source data are available online for this figure.
EMBO Molecular Medicine Vol 8 | No 8 | 2016 ª 2016 The Authors
EMBO Molecular Medicine Defective glutamate and K clearance in FHM2 cortex Clizia Capuani et al
976
Published online: June 27, 2016 
As a second approach to study whether there is a causative rela-
tionship between reduced rate of Glu clearance by astrocytes and
CSD facilitation, we investigated whether pharmacological reduction
of the rate of Glu clearance in WT mice to a value similar to that in
FHM2-KI mice reduces the threshold for CSD induction and
increases the velocity of CSD propagation to values similar to those
in the FHM2 mutants. To identify which concentration of drug
produced a slowing of the rate of Glu clearance in WT mice close to
that produced by the FHM2 mutation and obtain information on the
time necessary to reach steady-state inhibition, we measured
the STC in cortical slices from P22-23 WT mice before and after the
application of different subsaturating concentrations of DL-TBOA.
We identified a concentration of DL-TBOA (2.5 lM) that increased
by 32  2% the time constant of decay of the STC elicited by single
pulse stimulation, thus producing a slowing of the rate of Glu clear-
ance close to (although larger than) that produced by the FHM2
mutation (Fig 9A). In the presence of 2.5 lM DL-TBOA, the thresh-
old for CSD induction was 36% lower than in control (142  4
versus 220  8 ms), and the velocity of CSD propagation was 20%
higher (3.84  0.09 versus 3.21  0.08 mm/min) (Fig 9B). Thus,
pharmacological inhibition of a fraction of GluTs does facilitate CSD
induction and propagation in WT mice. In correlation with the
larger slowing of the rate of Glu clearance produced by TBOA 2.5
relative to that produced by the FHM2 mutation (32 versus 21%:
Figs 9A and 1C), the facilitation of CSD induction was also larger
(36% versus 28% lower CSD threshold in TBOA 2.5 versus KI,
respectively: Figs 9B and 6B), suggesting that the reduced rate of
Glu clearance in FHM2-KI mice may account for a large fraction of
the facilitation of CSD induction. To establish whether impaired Glu
clearance in FHM2-KI mice may completely account for the facilita-
tion of CSD induction, we measured CSD threshold and velocity in
the presence of a concentration of DL-TBOA (1.5 lM) that produced
a slowing of the rate of Glu clearance quantitatively similar to that
produced by the FHM2 mutation (22  3%: Fig 9C). In the presence
of 1.5 lM DL-TBOA, the threshold for CSD induction was 23%
lower than in control (170  5 versus 220  8 ms) and the velocity
of CSD propagation was 13% higher than in control WT slices
(3.61  0.09 versus 3.21  0.08) (Fig 9D). These data support the
conclusion that the reduced rate of Glu clearance in FHM2-KI mice
can account for most of the facilitation of CSD induction (82%, as
estimated from the ratio of the relative reductions of CSD threshold
produced by TBOA 1.5 and the FHM2 mutation: 23%/28%; cf also
similar CSD thresholds in WT TBOA 1.5 and FHM2 KI in Figs 9D
and 6B), while it can account for only a fraction of the facilitation of
CSD propagation in FHM2-KI mice (62%, as estimated from the
ratio 13/21 of the relative increases in CSD velocity produced by
TBOA 1.5 and the FHM2 mutation; cf also different CSD rates in WT
TBOA 1.5 and FHM2 KI: unpaired t-test, P < 0.001).
Discussion
We have studied the functional consequences of the reduced
membrane expression of the a2 NKA pump in heterozygous
W887R/+ FHM2-KI mice on the rate of Glu clearance by astrocytes
during neuronal activity, as measured from the decay kinetics of the
synaptically activated Glu transporter current recorded in cortical
astrocytes. We have shown that Glu clearance by astrocytes during
neuronal activity is slower in FHM2-KI compared to WT mice and
that the density of GLT-1a in the membrane of astrocytic processes
surrounding cortical excitatory synapses is about 50% reduced in
the FHM2 mutants, a reduction that mirrors the reduced expression
of the a2 NKA protein. Interestingly, the relative impairment of Glu
clearance in FHM2-KI mice is activity dependent. In fact, when
synaptic Glu release was induced by a train of pulses, the slowing
down of the rate of Glu clearance in the FHM2 mutants was larger
than that observed with a single pulse and was larger with a 100-Hz
compared to 50-Hz train. This is consistent with and likely reflects
the decreased Glu binding capacity of GluTs in the KI mice due to
the reduced density of GLT-1a in PAPs. As a consequence, a rela-
tively lower number of GluTs remain available to bind Glu at the
end of the train in KI compared to WT astrocytes, resulting in a rela-
tively larger slowing of the rate of Glu clearance.
These data provide the first direct experimental evidence, to our
knowledge, for a key role of the a2 NKA pump in the clearance of
synaptically released Glu during neuronal activity. Our findings
suggest that this key role is based on a necessary tight coupling
between the a2 pump and GLT-1 in cortical PAPs. These findings
include (i) the strict colocalization of a2 NKA and GLT-1a in astro-
cytic processes in the vicinity of glutamatergic synapses; (ii) the
48% reduction in the membrane density of GLT-1a in KI PAPs,
quantitatively similar to the reduction in the expression of a2 NKA,
and, in contrast, the unaltered membrane density of GLT-1a in AxTs
where a2 is not expressed; (iii) the insignificant increase in
Figure 8. The density of GLT-1a in the membrane of cortical perisynaptic astrocytic processes is not altered by ceftriaxone treatment in W887R/+ FHM2-KI
mice, while the density of GLT-1a in the axon terminals is increased.
A Distribution of GLT-1a gold particles in PAP of saline-injected (Ctr KI, N = 4) and Cef-treated KI mice (Cef KI, N = 4) (P45-46). Cef treatment does not modify the
density of total, cytoplasmic (arrows) and membrane-associated (arrowheads) gold particles in PAP of KI mice (see Table 2 for statistics).
B Distribution of GLT-1a gold particles in AxT in SI of Ctr KI and Cef KI mice. The density of the membrane-associated gold particles (arrowheads) is increased in Cef-
treated KI mice (see Table 2 for statistics). All microscopic fields in (A) and (B) are from layers II/III. t, total density; cyt, cytoplasmic density; mem, membrane density.
Scale bar: 100 nm.
C Western blottings of GLT-1a in cortical crude synaptic membranes of P39-KI mice following Cef treatment. GLT-1a levels are similar in Cef-treated (Cef KI, N = 4) and
saline-injected (Ctr KI, N = 4) (Mann–Whitney U-test: P = 0.83). Data are mean  SEM.
D Visualization of GLT-1a+ puncta (green) and VGLUT1+ puncta (red) in KI mice that received saline (Ctr KI) and in Cef-treated KI mice (Cef KI) (P45-46). Arrows point to
some GLT-1a/VGLUT1-related puncta; framed regions are examples of GLT-1a/VGLUT1-related puncta (arrowheads). Right, Cef treatment does not increase the size of
GLT-1a+ puncta overlaying with VGLUT1 (160 and 175 GLT-1a+ puncta analyzed from the same 4 Ctr KI and 4 Cef KI used for post-embedding electron microscopy
analysis; three sections/animal) (Mann–Whitney U-test: P = 0.31). Data are mean  SEM. Scale bar: 3.5 lm for left and right upper panels and 1 lm for enlarged
framed areas. All microscopic fields are from layers II/III.
Source data are available online for this figure.
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membrane density of GLT-1a in PAPs in Cef-treated FHM2-KI mice,
in contrast with the increased density of GLT-1a in AxTs.
By using astrocytes as [K]e biosensors, we have also studied the
functional consequences of the reduced expression of a2 NKA in
heterozygous W887R/+ KI mice on the rate of K+ clearance, as
measured from the decay kinetics of the [K+]e-dependent slow
inward current elicited in astrocytes by neuronal activity and the
ensuing K+ efflux. The finding that the rate of K+ clearance after a
train of pulses at 50 Hz is slower in FHM2-KI mice provides the first
direct experimental support for an important role of the a2 NKA
pump in K+ clearance following neuronal activity.
Can impaired Glu and K+ clearance during neuronal activity
explain the facilitation of initiation and propagation of experimental
CSD in the FHM2 mouse model and the episodic vulnerability to
CSD ignition in FHM2? Despite important progress, the mechanisms
underlying the initiation of experimental CSD remain incompletely
understood and controversial (Pietrobon & Moskowitz, 2014).
Experimental data and computational models support the ideas that
an increase in [K+]e above a critical value is a key initiating event
and that generation of a net self-sustaining inward current and a
regenerative local K+ release are essential components of the posi-
tive feedback cycle that confers to CSD its all-or-none characteristics
and causes a complete neuronal depolarization if the removal of K+
from the interstitium does not keep pace with its release (Somjen,
2001; Pietrobon & Moskowitz, 2014). The ion channels involved in
the generation of the net self-sustaining inward current and in the
regenerative local K+ release essential for CSD ignition remain
incompletely understood, although there is strong pharmacological
support for a key role of NMDARs (Pietrobon & Moskowitz, 2014).
Investigation of the mechanisms underlying the facilitation of exper-
imental CSD in FHM1-KI mice, carrying a gain-of-function mutation
in neuronal CaV2.1 channels, revealed an enhanced excitatory
synaptic transmission at cortical pyramidal cell synapses (Tottene
et al, 2009; Vecchia et al, 2015) and showed a causative link
between enhanced glutamatergic transmission at cortical synapses
and facilitation of initiation and propagation of experimental CSD
(Tottene et al, 2009).
Here, we investigated whether there is a causative relationship
between the reduced rate of Glu clearance at cortical synapses and
the facilitation of CSD in FHM2-KI mice, using two different
approaches.
In the first approach, we investigated whether the facilitation of
CSD in FHM2-KI mice could be rescued by systemic treatment with
Cef, a drug that increased around 60% the expression of GLT-1a in
neocortex of WT mice. Cef was able to rescue a small portion of the
facilitation of CSD induction without affecting the facilitation of CSD
propagation. The findings that neither the total expression of GLT-
1a in the cortex nor the membrane density of GLT-1a in PAPs was
significantly increased in Cef-treated FHM2-KI mice made it difficult
to draw a clearcut conclusion regarding the role of impaired Glu
clearance by astrocytes in CSD facilitation. The observation that Cef
increased GLT-1a expression in AxTs in FHM2-KI mice suggests the
possibility that the small increase in CSD threshold produced by Cef
may be due to the increased reuptake of Glu in AxTs. If correct, this
would be remarkable because GLT-1a in AxTs is only a small frac-
tion of the total brain GLT-1a (Chen et al, 2004; Furness et al, 2008;
Melone et al, 2009); accordingly, selective deletion of GLT-1a in
neurons does not give rise to any apparent neurological abnormality
in contrast with selective deletion in astrocytes (Petr et al, 2015).
Alternatively, some other effect of Cef, not related to GLT-1 expres-
sion, might underlie its small effect on CSD threshold, although the
unaltered protein levels of a2 NKA, xCT, and Kir4.1 in Cef-treated
FHM2-KI mice make the involvement of mechanisms mediated by
these proteins unlikely.
In the second approach, we investigated whether pharmacologi-
cal reduction in the rate of Glu clearance by astrocytes in WT mice
to values similar to those in FHM2-KI mice could lead to a similar
facilitation of CSD induction and propagation. Pharmacological inhi-
bition of a fraction of GluTs in WT mice did lower the threshold for
CSD induction and increased the velocity of CSD propagation. The
quantitative comparison between the changes in CSD threshold and
velocity produced by the FHM2 mutation and by subsaturating
concentrations of DL-TBOA supports the conclusion that the
reduced rate of Glu clearance by astrocytes can account for most of
the facilitation of CSD initiation in FHM2-KI mice, leaving little
room for other contributing mechanisms. In contrast, impaired Glu
clearance by astrocytes can account for only a (relatively large) frac-
tion of the facilitation of CSD propagation, suggesting that other
mechanisms contribute. The observation that also Cef treatment in
FHM2-KI mice had a differential effect on CSD threshold and veloc-
ity appears consistent with the interpretation that increased reup-
take of Glu in AxTs might account for the small rescue of facilitation
of CSD induction produced by Cef.
The present data, together with the findings in FHM1-KI mice
(Tottene et al, 2009), support a model of CSD initiation in which (i)
excessive glutamatergic synaptic transmission and activation of
Table 2. Density of GLT-1a gold particles in perisynaptic astrocytic processes and axon terminals of asymmetric synapses of saline (Ctr)- and
ceftriaxone (Cef)-treated W887R/+ FHM2-KI mice.
Density values are mean  SEM; n = the number of profiles. Comparison of densities between saline-treated (N = 4) and Cef-treated (N = 4) FHM2-KI mice was
made using Mann–Whitney U-test.
Localization Ctr KI (particles/lm2) Cef KI (particles/lm2) Ctr versus Cef
Nucleus (background) 0.51  0.03 (n = 25) 0.54  0.01 (n = 25)
Astrocytic processes 12.98  0.60 (n = 354) 13.26  0.71 (n = 380) P = 0.27
Plasma membrane 21.13  1.16 23.31  1.19 P = 0.27
Cytoplasm 11.70  0.86 10.52  0.83 P = 0.009
Axons terminal 5.10  0.30 (n = 158) 6.56  0.50 (n = 166) P = 0.002
Plasma membrane 14.40  1.22 18.50  1.18 P = 0.007
Cytoplasm 3.42  0.29 4.85  0.70 P = 0.068
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NMDARs are key elements in the positive feedback cycle that ignites
CSD and (ii) the a2 NKA pumps exert a dampening role owing
mainly to their key role in Glu clearance by astrocytes. There is
evidence that cooperative activation of postsynaptic NMDARs by
independent excitatory synapses due to Glu spillover occurs with,
for example, high-frequency stimulation or by increasing the proba-
bility of Glu release or with pharmacological inhibition of GluTs,
that is, in conditions in which the binding capacity of GluTs is
overwhelmed by high extracellular Glu (Lozovaya et al, 1999; Arnth-
Jensen et al, 2002; Tsukada et al, 2005). Most likely, cooperative
activation of postsynaptic NMDARs also occurs with the experimen-
tal stimuli that ignite CSD, since they induce a large release of Glu
(Pietrobon & Moskowitz, 2014; Enger et al, 2015). Within the frame-
work of the proposed CSD model, one predicts a lower threshold for
CSD induction in FHM2-KI compared to WT mice because in the
FHM2 mutants depolarizing stimuli of lower intensity will release
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Figure 9. Facilitation of CSD induction and propagation after pharmacological inhibition of a fraction of glutamate transporters in WT mice.
A sdecay of the STC evoked by single pulse stimulation in layer 1 astrocytes in acute cortical slices from P22-23 WT mice before (Ctr WT) and after the application of
2.5 lM DL-TBOA (TBOA 2.5) (n = 4; N = 2) (right panel). The traces on the left are the corresponding average normalized STCs, isolated as in Fig 1C. The STC sdecay in
TBOA 2.5 is 32  2% higher than in Ctr WT (paired t-test: **P = 0.002). The left top panel shows the time course of sdecay of the transient component (due to the STC)
of the current recorded in an astrocyte during a representative experiment in which TBOA 2.5 was applied at the time indicated by the horizontal bar. The steady-
state effect was reached within 10–15 min from the beginning of the drug perfusion. Data are mean  SEM.
B CSD threshold and velocity measured in cortical slices from P22-23 WT mice after perfusion for 20 min with extracellular solution without (Ctr WT: n = 23; N = 15)
and with 2.5 lM DL-TBOA (TBOA 2.5: n = 25; N = 8). CSD threshold in TBOA 2.5 is 36% lower than in Ctr WT (Mann–Whitney U-test: ***P < 0.0001) and CSD velocity
is 20% higher (unpaired t-test: ***P < 0.0001). Data are mean  SEM.
C sdecay of the STC evoked by single pulse stimulation in layer 1 astrocytes in acute cortical slices from P22-23 WT mice before (Ctr WT) and after the application of
1.5 lM DL-TBOA (TBOA 1.5) (n = 4; N = 4). The STC sdecay in TBOA 1.5 is 22  3% higher than in Ctr WT (paired t-test: **P = 0.004). Data are mean  SEM.
D CSD threshold and velocity measured in cortical slices from P22-23 WT mice after perfusion for 20 min with extracellular solution without (Ctr WT: n = 23; N = 15)
and with 1.5 lM DL-TBOA (TBOA 1.5: n = 18; N = 6). CSD threshold in TBOA 1.5 is 23% lower than in Ctr WT (Mann–Whitney U-test: ***P < 0.0001) and CSD velocity
is 13% higher (unpaired t-test: **P = 0.003). Data are mean  SEM.
Source data are available online for this figure.
EMBO Molecular Medicine Vol 8 | No 8 | 2016 ª 2016 The Authors
EMBO Molecular Medicine Defective glutamate and K clearance in FHM2 cortex Clizia Capuani et al
980
Published online: June 27, 2016 
enough Glu to overwhelm the binding capacity of GluTs and lead to
cooperative activation of a sufficient number of NMDARs to initiate
the positive feedback cycle that ignites CSD. The findings discussed
above indicate that the contribution of the reduced rate of K+ clear-
ance by astrocytes to the facilitation of CSD initiation in FHM2-KI
mice, if present, is quite small. This would be consistent with a
more relevant role of the neuronal a3 NKA relative to the glial a2
NKA in K+ buffering during the CSD-inducing stimuli. Evidence that
this is the case during the CSD depolarization is provided by reports
that the duration of the CSD depolarization is increased in heterozy-
gous KI mice carrying a mutation that reduces the activity of a3
NKA (Hunanyan et al, 2015), whereas, in contrast, the CSD dura-
tion is not affected in FHM2-KI mice with reduced a2 NKA (Leo
et al, 2011).
The typical slow rate of CSD propagation implies that it is
mediated by diffusion of a chemical substance. Although it has long
been debated whether the diffusing substance is K+ or Glu, most
evidence points to the diffusion of K+ released into the interstitial
space during CSD as the underlying mechanism (Pietrobon &
Moskowitz, 2014; Enger et al, 2015). The very fast rate of Glu
clearance compared to that of K+ clearance is consistent with and
supports this notion. The faster rate of CSD propagation in FHM2-KI
mice is consistent with the idea that CSD propagation is mediated
by K+ diffusion because, in the framework of our CSD model, one
predicts that in KI mice the [K+]e-dependent Glu release necessary
to activate a number of NMDARs sufficient for ignition of CSD in
contiguous regions is obtained when the propagating K+ ions reach
a lower concentration than in WT mice. Moreover, it is plausible
to expect that the reduced rate of K+ clearance by astrocytes in
FHM2-KI mice increases the rate of CSD spread and thus contributes
to the facilitation of CSD propagation.
Since activity-dependent intracellular Na+ transients in
hippocampal and cortical astrocytes are predominantly due to Na+
influx mediated by GluTs (Chatton et al, 2000; Langer & Rose, 2009;
Lamy & Chatton, 2011), and since in our FHM2-KI mice the reduced
expression of a2 NKA is accompanied by a similar reduction in GLT-1
in PAPs, it remains unclear whether and to what extent activity-
dependent Na+ transients are altered in the astrocytes of FHM2-KI
mice. However, if the reduced a2 NKA expression in FHM2-KI mice
significantly affects Na+ homeostasis in cortical astrocytes, other
possible hypothetical mechanisms that might contribute to CSD
facilitation (to be possibly investigated in future studies) could
result from slowing (or even reversal) of Na+-dependent trans-
porters such as the electrogenic Na+/HCO3 cotransporters or the
Na+/Ca2+ exchangers (Kirischuk et al, 2012; Rose & Karus, 2013)
(see Discussion in Appendix).
Both FHM2 and FHM1 mouse models are characterized by exces-
sive glutamatergic transmission, due to either increased Glu release
(FHM1) or reduced Glu clearance (FHM2). In contrast with the
enhanced excitatory synaptic transmission at pyramidal cell
synapses, inhibitory transmission at fast-spiking and other multipo-
lar interneuron synapses was unaltered in FHM1-KI mice (Tottene
et al, 2009; Vecchia et al, 2014, 2015). Interestingly, in the cortex,
the a2 NKA pump is localized in astrocytic processes surrounding
glutamatergic synapses, but is not present in astrocytic processes
surrounding GABAergic synapses (Cholet et al, 2002), suggesting
that FHM2 mutations likely affect excitatory but not inhibitory
synaptic transmission. The differential effect of FHM1 and FHM2
mutations on excitatory and inhibitory synaptic transmission
implies that, most likely, the neuronal circuits that dynamically
maintain a tight balance between excitation and inhibition during
cortical activity are functionally altered in FHM1 and FHM2, and
suggests that dysfunctional regulation of the cortical excitatory inhi-
bitory balance (E/I) may be a common feature of the FHM brain.
This supports the view of migraine as a disorder of brain excitability
characterized by dysfunctional regulation of the cortical E/I balance
(Vecchia & Pietrobon, 2012; Ferrari et al, 2015) and gives insights
into possible mechanisms underlying the susceptibility to ignition of
“spontaneous” CSDs in FHM, and possibly migraine. It seems plau-
sible to hypothesize that excessive glutamatergic transmission and
dysfunctional regulation of the E/I balance in FHM may in certain
conditions (e.g., with sensory overload or with other migraine trig-
gers) lead to overexcitation and network hyperactivity with the
consequent excessive K+ increase and NMDAR activation (that
leads to further K+ increase), thus creating the conditions for initia-
tion of the positive feedback cycle that ignites CSD. Similar mecha-
nisms may underlie the susceptibility to CSD ignition in common
forms of migraine for which there is indirect evidence consistent with
enhanced cortical excitatory transmission (Pietrobon & Moskowitz,
2013) and for which genome-wide association studies have identified
susceptibility loci potentially leading to enhanced glutamatergic
transmission and/or dysregulated brain E/I balance (Anttila et al,
2010, 2013; Chasman et al, 2011; Freilinger et al, 2012).
Materials and Methods
Animals
Experiments were performed using heterozygous knockin (KI) mice
harboring the W887R FHM2 mutation (Atp1a2+/R887 mice: Leo et al,
2011) and their wild-type (WT) littermates (background C57BL6J,
male and female in equal or near equal number). Animals were housed
in specific pathogen free conditions, maintained on a 12-h light/dark
cycle, with free access to food and water. Animals were anesthetized
with isoflurane or an intraperitoneal (i.p.) injection of chloral hydrate
(300 mg/kg) and the brains removed for acute slices preparation or
prepared for immunocytochemistry and Western blotting studies. For
Cef studies, mice received a daily i.p. injection (8–10 A.M) of saline or
Cef (Rocefin, Roche S.p.A., Milano, Italy; 200 mg/kg/day dissolved in
saline) for 7–8 days. Twenty-four hours after the final injection, the
animals were anesthetized and brains removed. All experimental
procedures involving animals and their care were carried out in
accordance with National laws and policies (D.L. n. 26, March 14,
2014) and with the guidelines established by the European Commu-
nity Council Directive (2010/63/UE) and were approved by the local
authority veterinary services.
Statistics
After assessing for normal distribution (using the Shapiro–Wilk or
the Kolmogorov–Smirnov test), comparison between two groups
was made using two-tailed unpaired or paired t-test for normal
distributed data or the Mann–Whitney U-test for nonparametric
data. Equal variances were assumed. Data are given as
mean  SEM; differences were considered statistically significant if
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P < 0.05 (*P < 0.05; **P < 0.01; ***P < 0.001). No statistical meth-
ods were used to choose sample sizes that were estimated based on
previous experience and are in line with those in the literature. No
animals were excluded from the analysis.
Electrophysiology
Whole-cell patch-clamp recordings from astrocytes in acute brain slices
Acute coronal slices of the somatosensory cortex were prepared from
P22-23 mice (unless otherwise specified) of either sex as described
in Tottene et al (2009) and in Appendix Supplementary Methods.
Patch-clamp recordings were made following the standard tech-
niques. Brain slices were continuously perfused in a submersion
chamber with fresh extracellular solution at 30°C at a flow rate of
3 ml/min. Recordings were made from layer 1 astrocytes deeper
than 45 lm from the slice surface. The cell bodies of astrocytes were
visualized using an upright microscope equipped with infrared light
and DIC optics and identified by their small soma size (< 10 lm),
low input resistance (< 20 MO; WT: 13.2  0.7 MO, n = 42; KI:
14.2  1.2 MO, n = 24; P = 0.42), very negative resting membrane
potential (WT: 91  0.6 mV, n = 42; KI: 91  0.6 mV, n = 24,
after LJP correction of 10 mV), inability to generate action poten-
tials and linear current–voltage relationships, typical of so-called
passive astrocytes (Bergles & Jahr, 1997; Bernardinelli & Chatton,
2008) (Scimemi & Diamond, 2013).
Astrocyte internal solution contained (in mM) 115 K-gluconate,
6 KCl, 4 MgATP, 0.3 NaGTP, 10 Na-phosphocreatine, 10 HEPES,
5 glucose (pH 7.25 with KOH, osmolarity 295 mOsm with sucrose).
The extracellular solution contained 125 mM NaCl, 2.5 mM KCl,
1 mM MgCl2, 1 mM CaCl2, 25 mM NaHCO3, 1.25 mM NaH2PO4,
25 mM glucose, saturated with 95% O2 and 5% CO2. For the record-
ing of Glu transporter-mediated currents, the extracellular solution
also contained antagonists of AMPA receptors (10 lM NBQX),
NMDA receptors (NMDARs; 50 lM D-AP5 and 20 lM (+)-MK801),
and GABAA receptors (20 lM (+)-bicuculline or 5 lM gabazine) to
block neuronal postsynaptic current flow (Bergles & Jahr, 1997).
Currents were evoked in astrocytes (held close to the resting
potential at -90 mV, after LJP correction) by passing constant current
pulses (100 lA, 100 ls) every 15 s (or 20 s with train of pulses)
through a concentric bipolar tungsten electrode (TM33CCINS, World
precision Instruments, Inc., Sarasota, FL, USA) placed in layer 1 at
least 200 lm away from the recorded astrocyte (Fig 1A). Access
resistance was monitored continuously throughout the experiments
and was typically < 20 MO (without compensation); experiments
where it changed more than 20% (or had access resistance
> 25 MO) were excluded from the data. The recorded WT and KI
astrocytes had similar access resistance (WT: 14.7  0.6 MO,
n = 66; KI: 16.0  0.8 MO, n = 47; P = 0.15). Pipette resistance was
5–6 MO. Currents were sampled at 10 kHz and filtered at 2 kHz.
Analysis of patch-clamp recordings
Synaptically activated Glu transporter currents (STCs) elicited by
single pulse stimulation were isolated pharmacologically using
saturating concentrations of the GluTs inhibitor (3S)-3-[[3-
[[4-(trifluoromethyl)benzoyl]amino]phenyl]methoxy]-L-aspartic acid
(TFB-TBOA; Tocris Cookson Ltd., Bristol, UK) (0.5–15 lM). The
STC was obtained by subtracting the residual current remaining in
the presence of TFB-TBOA (TBOA) from the total control current
(Scimemi & Diamond, 2013). To obtain a measure of the rate of
clearance of synaptically released Glu by cortical astrocytes, the
decay of the STC was best fitted by a single exponential function
(Diamond, 2005). STCs elicited by single pulse stimulation were
also isolated nonpharmacologically by using an exponential wave-
form approximating the average TBOA-insensitive current
(Diamond, 2005; Devaraju et al, 2013; Scimemi & Diamond, 2013).
The average normalized residual current recorded in the presence of
TBOA was obtained by pooling the normalized TBOA-insensitive
currents recorded in 16 slices (recordings from 7 WT and 9 FHM2
astrocytes were pooled together because the time course of the
residual current in WT and KI slices was similar). The rising phase
of the average normalized TBOA-insensitive current was approxi-
mated by a monoexponential function (1-exp (t/srise)) with
srise = 2.35 ms (Fig 1C). The STC was obtained by subtracting from
the total current elicited in astrocytes an exponential function
A(1-exp (t/srise)) with srise = 2.35 ms and with A equal to the maximal
current measured in individual astrocytes at about 60 ms after stim-
ulation when the transient transporter current had decayed to zero
(Diamond, 2005; Devaraju et al, 2013; Scimemi & Diamond, 2013).
When STCs were elicited by trains of 10 pulses at high frequency
(50 or 100 Hz), it was not possible to isolate them pharmacologi-
cally (by subtracting the residual current in the presence of TBOA
from the control current elicited by the train) because in the pres-
ence of TBOA the residual current measured after the train was
larger than in control. Therefore, the STC elicited by the 10th pulse
in the train was obtained from experiments in which single stimuli
were alternated with trains of 9 and 10 pulses at 50 or 100 Hz
(Diamond & Jahr, 2000) as follows. First, the current elicited by 9
pulses was subtracted from that elicited by 10 pulses (Fig 2A, left) to
obtain the 10-9 pulses difference current (trace a-b); then, the STC
elicited by the 10th pulse (Fig 2A, right: trace a-b-c) was obtained in
isolation by subtracting the exponential function that simulates the
TBOA-insensitive current elicited by a single pulse (trace c, obtained
as explained above) from the 10-9 pulses difference current (trace
a-b) (Fig 2A, right). This could be done because the amplitude of the
TBOA-insensitive current elicited by a single pulse was similar to the
amplitude of the steady component of the 10-9 pulses difference
current (e.g. WT: 23  3 pA versus 21  3 pA with 50-Hz train,
n = 19; 21  3 pA versus 20  2 pA with 100-Hz train, n = 14; simi-
lar finding for KI: 25  6 pA versus 24  5 pA with 50-Hz train,
n = 15; 32  7 pA versus 27  5 pA with 100-Hz train, n = 11).
Sweeps are averages of at least five responses. Stimulation arti-
facts have been truncated.
Cortical spreading depression
Cortical spreading depression was elicited and measured in acute
coronal slices of the somatosensory cortex of WT and FHM2-KI mice
as in Tottene et al (2009), but most recordings were at 30°C rather
than at room temperature and the rate of perfusion of the slices was
higher (6 ml/min, unless otherwise specified). See Appendix Supple-
mentary Methods for details.
Immunocytochemical studies
Mice were anesthetized with an i.p. injection of chloral hydrate
(300 mg/kg) and perfused transcardially with a flush of saline
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solution followed by 4% freshly depolymerized paraformaldehyde
in 0.1 M phosphate buffer (PB; pH 7.4). Brains were removed, post-
fixed in the same fixative (4 weeks for both double-labeling
immunofluorescence and immunogold studies; 2 h for triple-
labeling immunofluorescence observations), and cut in coronal
sections on a vibratome in 50-lm sections that were collected in PB
until processing (Melone et al, 2009).
Immunofluorescence
GLT-1a/VGLUT1 double-labeling studies were performed in
sections from WT and KI mice and then, in a second set of
experiments, in sections from saline- or Cef-treated WT mice and
saline- or Cef-treated KI mice. To minimize the effects of procedu-
ral variables, GLT-1a/VGLUT1 double-labeling staining of sections
from WT and KI groups and then of WT saline, WT Cef, KI
saline, and KI Cef groups was performed in parallel using well-
characterized antibodies (Rothstein et al, 1994; Melone et al,
2005; Omrani et al, 2009) and standard procedures as described
in Melone et al (2009) and detailed in Appendix Supplementary
Methods.
Confocal microscopy and data analysis
Collection and data analysis of confocal microscopic fields were
performed by a blinded observer. Procedures were as described
previously (Melone et al, 2005, 2009; Bragina et al, 2006) and are
detailed in Appendix Supplementary Methods.
Immunogold
Sections from WT and KI animals and from KI mice that received
saline or Cef were processed for the osmium-free method (Phend
et al, 1995). Procedures were as described previously (Melone et al,
2009) and are detailed in Appendix Supplementary Methods. To
minimize the effects of procedural variables, post-embedding proce-
dure of grids from WT and KI groups and then from KI saline and KI
Cef groups was performed in parallel.
Electron microscopy and data analysis
Collection and analysis of electron microscopic fields were
performed by a blinded observer as described (Melone et al, 2009)
and detailed in Appendix Supplementary Methods.
Western blotting
For western blotting studies, mice were anesthetized with chloral
hydrate (300 mg/kg i.p.) and decapitated. Cerebral cortex was
quickly separated, tissue was homogenized (Melone et al, 2001),
and crude synaptic membranes were prepared (Danbolt et al, 1990).
To minimize the procedural variables, homogenates from Cef and
saline mice were loaded onto the same gel and in a blinded manner.
Procedures were as described (Bragina et al, 2006) and detailed in
Appendix Supplementary Methods, together with antibodies and
controls.
Expanded View for this article is available online.
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The paper explained
Problem
Migraine is a common disabling brain disease. Cortical spreading
depression (CSD) is thought to play a key role in migraine pathogene-
sis in that it underlies migraine aura and may trigger migraine head-
ache. The mechanisms of the primary brain dysfunction underlying
the susceptibility to CSD ignition in the human brain and the onset of
a migraine attack remain largely unknown and are a major open issue
in the pathophysiology of migraine. To gain insights into this ques-
tion, we studied the mechanisms underlying facilitation of CSD in a
knockin (KI) mouse model of familial hemiplegic migraine type 2
(FHM2), a rare monogenic form of migraine with aura caused by loss-
of-function mutations in the gene encoding the a2 subunit of the
Na+, K+ ATPase (a2 NKA), an isoform almost exclusively expressed in
astrocytes in the adult brain.
Results
Combining patch-clamp recordings from astrocytes in acute cortical
slices with immunohistochemistry and immunogold electron micro-
scopy, we show that (i) the rates of glutamate and K+ clearance by
cortical astrocytes during neuronal activity are reduced in heterozy-
gous KI mice that carry the W887R FHM2 mutation and have 50%
reduced a2 NKA protein in the brain, thus providing direct evidence for
a key role of a2 NKA in clearance of synaptically released glutamate
and in extracellular K+ buffering during neuronal activity and (ii) the
density of GLT-1a glutamate transporters in the membrane of astro-
cytic processes surrounding cortical excitatory synapses is about 50%
reduced in the FHM2 mouse model, pointing to a specific tight
coupling between a2 NKA and GLT-1a in the astrocytic processes.
Measurements of CSD threshold and velocity in cortical slices from
FHM2-KI mice treated with ceftriaxone and from wild-type mice after
pharmacological inhibition of a fraction of glutamate transporters
provide evidence that the defective glutamate clearance by astrocytes
underlies most of the facilitation of CSD initiation (and a large fraction
of the facilitation of CSD propagation) in the FHM2 mouse model.
Impact
By uncovering the key mechanism underlying the facilitation of CSD
in the FHM2 mouse model, this study moves forward our understand-
ing of the molecular and cellular mechanisms that may underlie the
brain susceptibility to CSD ignition in migraine and point out a direc-
tion in which to search for novel migraine therapies. In particular, it
points to excessive cortical glutamatergic synaptic transmission as a
key mechanism underlying vulnerability to CSD ignition in migraine
and to the enhancement of astrocytic glutamate transporter function
as a possible new therapeutic strategy.
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